The Bax exon 2 splicing had no statistical correlation with the AD patient’s APOE genotypes (apolipoprotein E, especially APOE4, is a well-documented genetic risk factor for Alzheimer’s disease) [41] (Figure 2e). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.